A First in Class Product that can act as a “Platform” Applicable to Multiple Diseases
Chief Executive Officer
Chief Financial Officer
Chief Scientific Officer
Is the Stacy Joy Goodman Professor of Surgery, Distinguished Professor of Medicine, Professor of Biomedical Engineering, and Microbiology and Immunology at the University of Miami (UM), Florida, where he serves as Director of the Diabetes Research Institute and the Cell Transplant Center.
Boris Reznik is the Chairman of Venvalo Group. During his career spanning four decades, Dr. Reznik founded and built technology companies into market leaders, managed high growth, profitable enterprises and successfully dealt with both Fortune 500 and emerging companies as clients and partners. He has been a lead or co-investor in multiple technology-based companies and has participated in many public and private fundings and mergers and acquisitions of technology-based companies, ranging from Millions to Billions.
Director of Cardiology, Christ Hospital, Cincinnati, OH. Dr. Henry’s experience also includes Director of Research at Minneapolis Heart Institute Foundation.
Director, Neuro-oncology; Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute